Scientific reports

International journal of molecular sciences

Journal of colloid and interface science

Cells

journal of neuro-oncology

European radiology

BMC cancer

journal of neurosurgery

neuroimage clinical

acta neuropathologica

journal of cellular physiology

cancer cell international

experimental cell research

bmc medical genomics

The International journal of neuroscience

Pneumologie

Frontiers in cell and developmental biology

swiss medical weekly

current opinion in neurology

fundamental & clinical pharmacology

[1] An update on the CNS manifestations of neurofibromatosis type 2.

[2] Peripheral vestibular disorders: an update.

[3] Dizziness in the emergency department: an update on diagnosis.

[4] The effects of melatonin on signaling pathways and molecules involved in glioma.

[5] Metabolic Reprogramming in Glioma.

[6] Spatial distribution of malignant transformation in patients with low-grade glioma.

[7] Enhancing selective photosensitizer accumulation and oxygen supply for high-efficacy photodynamic therapy toward glioma by 5-aminolevulinic acid loaded nanoplatform.

[8] Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway.

[9] Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.

[10] Quantification and visualization of lipid landscape in glioma using in -and opposed-phase imaging.

[11] Eslicarbazepine in Patients with Brain Tumor-Related Epilepsy: A Single-Center Experience.

[12] frequency of epstein-barr virus dna sequences in human gliomas

[13] proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions

[14] neuroimaging of adult gliomas: an update

[15] immune-checkpoint blockade and active immunotherapy for glioma

[16] leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate snp approach

[17] sevoflurane regulates glioma progression by circ_0002755/mir-628-5p/magt1 axis

[18] bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern

[19] inhibition of tumor growth, angiogenesis, and microcirculation by the novel flk-1 inhibitor su5416 as assessed by intravital multi-fluorescence videomicroscopy

[20] an overview of therapeutic approaches to brain tumor stem cells

[21] comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric mri

[22] epstein–barr virus in gliomas: cause, association, or artifact?

[23] cellular high-energy cavitation trauma - description of a novel in vitro trauma model in three different cell types.

[24] the usefulness of arcuate fasciculus tractography integrated navigation for glioma surgery near the language area; clinical investigation

[25] correlation of mir-221 expression with pten/akt signal pathway and emt-related gene expression in glioma tissue

[26] the controversy about a possible relationship between mobile phone use and cancer a controvérsia sobre a possível relação entre o uso do telefone celular e câncer

[27] emerging insights into barriers to effective brain tumor therapeutics

[28] positive expression of kif20a indicates poor prognosis of glioma patients

[29] metabolomics of therapy response in preclinical glioblastoma: a multi-slice mrsi-based volumetric analysis for noninvasive assessment of temozolomide treatment

[30] the use of convection-enhanced delivery with liposomal toxins in neurooncology

[31] anti-inflammatory and antitumor effects of hydroxytyrosol but not oleuropein on experimental glioma in vivo. a putative role for the renin-angiotensin system

[32] role of akt isoforms controlling cancer stem cell survival, phenotype and self-renewal

[33] immunosuppressive mechanisms of malignant gliomas: parallels at non-cns sites

[34] new trends in cancer therapy: targeting ion channels and transporters

[35] the tyrosine kinase pyk2 promotes migration and invasion of glioma cells

[36] remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy

[37] microrna in human glioma

[38] analysis of mammalian septin expression in human malignant brain tumors

[39] genetically engineered multilineage-differentiating stress-enduring cells as cellular vehicles against malignant gliomas

[40] up-regulation of long non-coding rna ab073614 predicts a poor prognosis in patients with glioma

[41] advanced mri increases the diagnostic accuracy of recurrent glioblastoma: single institution thresholds and validation of mr spectroscopy and diffusion weighted mr imaging

[42] Abstracts from the 2012 BNOS Conference

[43] Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research

[44] CHRDL1 Regulates Stemness in Glioma Stem-like Cells.

[45] [Test Your Knowledge].

[46] Gene Expression of /CD114 Is Associated with Poorer Patient Survival in Glioma.

[47] A proof-of-principle for decontamination of transplantation kidney through UV-C exposition of the perfusate solution.

[48] Flavonoids inhibit angiogenic cytokine production by human glioma cells.

[49] Extraneural Metastasis of Primary Glioma Occurring in a Setting of Occupational Ionizing Radiation Exposure

[50] Carotid Paraganglioma in Adolescence-Clinical Picture-Surgical Technique and Review of the Literature

[51] Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.

[52] Conditioned Media from Human Adipose Tissue-Derived Mesenchymal Stem Cells and Umbilical Cord-Derived Mesenchymal Stem Cells Efficiently Induced the Apoptosis and Differentiation in Human Glioma Cell Lines In Vitro

[53] Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.

[54] Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.

[55] Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste

[56] Tumor border sharpness correlates with HLA-G expression in low-grade gliomas.

[57] Stoichioproteomics reveal oxygen usage bias, key proteins and pathways in glioma.

[58] Long Intergenic Non-coding RNA Profiles of Pheochromocytoma and Paraganglioma: A Novel Prognostic Biomarker.

[59] A negative feedback loop of H19/miR-675/VDR mediates therapeutic effect of cucurmin in the treatment of glioma.

[60] Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma (Scientific Reports, (2018), 8, 1, (2339), 10.1038/s41598-018-20844-w)

[61] Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment

[62] The effect of marital status on glioma patient survival: analysis of 617 cases: A SEER-based study.

[63] Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.

[64] FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas.

[65] Author Correction: Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition (Cell Death Discovery, (2019), 5, 1, (72), 10.1038/s41420-019-0155-9)

[66] Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma

[67] GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis.

[68] Predicting the 1p/19q co-deletion status of presumed low grade glioma with an externally validated machine learning algorithm.

[69] Impact of facility type and volume in low-grade glioma outcomes.

[70] Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.

[71] Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.

[72] Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.

[73] Pediatric ganglioglioma of the brainstem and cervicomedullary junction: a retrospective cohort study.

[74] Preimplantation genetic diagnosis for a single gene mutation for succinate dehydrogenase subunit B (the genetic basis for malignant paraganglioma) with successful pregnancy

[75] PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

[76] Targeted brain delivery nanoparticles for malignant gliomas.

[77] A Novel Deep Learning Algorithm for the Automatic Detection of High-Grade Gliomas on T2-Weighted Magnetic Resonance Images: A Preliminary Machine Learning Study.

[78] Outcome Prediction for Patient with High-Grade Gliomas from Brain Functional and Structural Networks.

[79] HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53.

[80] The effects of melatonin on signaling pathways and molecules involved in glioma.

[81] Advanced imaging in adult diffusely infiltrating low-grade gliomas.

[82] Metabolic Reprogramming in Glioma.

[83] Author Correction: The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells

[84] Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway

[85] Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

[86] Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway.

[87] Glioma Mimics: Magnetic Resonance Imaging Characteristics of Granulomas in Dogs

[88] Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study.

[89] Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.

[90] Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.

[91] MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2.

[92] Spatial distribution of malignant transformation in patients with low-grade glioma.

[93] Enhancing selective photosensitizer accumulation and oxygen supply for high-efficacy photodynamic therapy toward glioma by 5-aminolevulinic acid loaded nanoplatform.

[94] Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway.

[95] Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.

[96] Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.

[97] Signaling Determinants of Glioma Cell Invasion.

[98] Cytoskeleton and Nucleotide Signaling in Glioma C6 Cells.

[99] Lipid Fraction Derived From MRI In- and Opposed-Phase Sequence as a Novel Biomarker for Predicting Survival Outcome of Glioma.

[100] Quantification and visualization of lipid landscape in glioma using in -and opposed-phase imaging.

[101] Adenosine Signaling in Glioma Cells.